Azelnidipine
Clinical data | |
---|---|
Trade names | CalBlock |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 123524-52-7 |
PubChem (CID) | 65948 |
ChemSpider | 59352 |
UNII | PV23P19YUG |
KEGG | D01145 |
ChEMBL | CHEMBL1275868 |
Chemical and physical data | |
Formula | C33H34N4O6 |
Molar mass | 582.64 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Azelnidipine (INN; marketed under the brand name CalBlock — カルブロック) is a dihydropyridine calcium channel blocker. It is sold in Japan by Daiichi-Sankyo pharmaceuticals, Inc. Unlike nicardipine, it has a gradual onset and has a long-lasting hypotensive effect, with little increase in heart rate.[1]
References
- ↑ Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T (September 1989). "Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker". Jpn. J. Pharmacol. 51 (1): 57–64. doi:10.1254/jjp.51.57. PMID 2810942.Scholar search
This article is issued from Wikipedia - version of the 8/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.